Loading data
AURNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3 m USD | 0 USD | 0 USD | 68 m USD | 82 m USD |
| Cost of revenue | 17 m USD | 0 USD | 0 USD | — | — |
| Research and development expense | 745 m USD | 676 m USD | 716 m USD | 677 m USD | 697 m USD |
| Selling, general and administrative expense | 142 m USD | 110 m USD | 119 m USD | 129 m USD | 116 m USD |
| Operating profit | -901 m USD | -786 m USD | -835 m USD | -1.85 bn USD | -731 m USD |
| Profit before tax | -816 m USD | -748 m USD | -796 m USD | -1.72 bn USD | -760 m USD |
| Income tax expense | 0 USD | 0 USD | 0 USD | 0 USD | -5 m USD |
| Net income (reported basis) | -816 m USD | -748 m USD | -796 m USD | -1.72 bn USD | -755 m USD |
| Basic earnings per share | -0.44 USD/share | -0.46 USD/share | -0.6 USD/share | -1.51 USD/share | -1.22 USD/share |
| Diluted earnings per share | -0.44 USD/share | -0.46 USD/share | -0.6 USD/share | -1.51 USD/share | -1.22 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.